Search Login Register

Activated Protein C Resistance (APC Resistance) Summary

947 relevant articles (13 outcomes, 80 trials/studies) found for this Disease

Description: A hemostatic disorder characterized by a poor anticoagulant response to activated protein C (APC). The activated form of Factor V (Factor Va) is more slowly degraded by activated protein C. Factor V Leiden mutation (R506Q) is the most common cause of APC resistance.

Also Known As: APC Resistance; Resistance, APC

Key Drugs and Agents for Activated Protein C Resistance

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Factor V (Coagulation Factor V) : 8 outcomes 16 studies in 254 results : IBA
  2. factor V Leiden : 7 outcomes 28 studies in 358 results : IBA
  3. Prothrombin (Factor II) : 3 outcomes 3 studies in 107 results : IBA
  4. Protein C : 2 outcomes 22 studies in 420 results : IBA
  5. Protein S : 2 outcomes 10 studies in 190 results : IBA
  6. DNA (Deoxyribonucleic Acid) : 2 outcomes 2 studies in 31 results : IBA
  7. Thrombin : 1 outcome 5 studies in 57 results : IBA
  8. Lupus Coagulation Inhibitor (Lupus Anticoagulant) : 1 outcome 2 studies in 66 results : IBA
  9. A-factor (Streptomyces) : 1 outcome 1 study in 20 results : IBA
  10. Anticoagulants : 1 outcome in 15 results : IBA
Show All >>

Diseases Related to Activated Protein C Resistance

  1. Thrombosis (Thrombus)
  2. Venous Thromboembolism
  3. Venous Thrombosis (Deep-Vein Thrombosis)
  4. Thrombophilia
  5. Pre-Eclampsia (Preeclampsia)
Show All >>

Key Therapies for Activated Protein C Resistance

Efficacy Chart >>
  1. Hormone Replacement Therapy (Therapy, Hormone Replacement) : 2 studies in 6 results
  2. Transplants (Transplant) : 1 study in 5 results
  3. Liver Transplantation : 10 results
  4. Transplantation (Transplant Recipients) : 4 results
  5. Homologous Transplantation (Allograft) : 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.